twenty-nine patients with stage iii and iv diffuse histiocytic lymphoma ( dhl ) were treated prospectively with cyclophosphamide , hydroxydaunorubicin , vincristine , prednisone and bleomycin ( chop-b ) or hydroxydaunorubicin , cyclophosphamide , vincristine , methotrexate with leucovorine rescue and cytosine arabinoside ( acomla ) .
C0055599
chop-b
C0013089
hydroxydaunorubicin